6.5 C
December 7, 2022
2020 – 2022 © MO.CO.HU Magyarország Hírek, Hungary News
Image default
AI Bank Finance British Patient Capital Deep Tech Featured funding HÍREK M Ventures Medtech Nucleome Therapeutics oxford Oxford Science Enterprises Series A The South East of England VC Funding VILÁG ANGOL

Startup using machine learning to find new medicines raises £38m

Biotech startup Nucleome Therapeutics has raised £37.5m in an oversubscribed Series A round to discover new medicines by decoding the human genome.

The investment will be spent on Nucleome’s autoimmune disease programmes alongside further research and development.

Dr Danuta Jeziorska, CEO and co-founder of Nucleome Therapeutics, said: “We have already made significant progress by mapping genes to genetics in a number of human immune cell types and discovering the first wave of potential first-in-class autoimmune disease targets”

Oxford-spinout Nucleome Therapeutics has found a way to look at the dark area of the human genome, an area where 90% of disease-associated genetic changes occur and holds promise for discovering new drugs.

Led by M Ventures, the Nucleome Therapeutics Series A also saw capital invested by Johnson and Johnson, Pfizer Ventures, British Patient Capital and Oxford Science Enterprises.

“Nucleome’s differentiated platform technology has the potential to fundamentally shift the way we discover and develop precision medicines,” said Dr Bauke Anninga, principal, M Ventures.

“We are excited to lead this financing, and alongside our co-investors, partner with Nucleome’s exceptional team to advance their target and drug discovery programmes to bring transformative treatments to patients.”

The post Startup using machine learning to find new medicines raises £38m appeared first on UKTN | UK Tech News.

Related posts

From dystopia to utopia: How UK co-working spaces are redefining the new normal


Mott MacDonald Ventures pumps in £4.7M funding in London cleantech Piclo


UK-based Forward Advances raises £2.2M to build fully customisable financing solution for entrepreneurs


DMCA.com Protection Status